The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors
Abstract
Induced pluripotent stem (iPS) cells have been generated from mouse and human somatic cells by introducing Oct3/4 and Sox2 with either Klf4 and c-Myc or Nanog and Lin28 using retroviruses or lentiviruses. Patient-specific iPS cells could be useful in drug discovery and regenerative medicine. However, viral integration into the host genome increases the risk of tumorigenicity. Here, we report the generation of mouse iPS cells without viral vectors. Repeated transfection of two expression plasmids, one containing the complementary DNAs (cDNAs) of Oct3/4, Sox2, and Klf4 and the other containing the c-Myc cDNA, into mouse embryonic fibroblasts resulted in iPS cells without evidence of plasmid integration, which produced teratomas when transplanted into mice and contributed to adult chimeras. The production of virus-free iPS cells, albeit from embryonic fibroblasts, addresses a critical safety concern for potential use of iPS cells in regenerative medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Self-citationInduction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Self-citationInduced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Efficient selection for high-expression transfectants with a novel eukaryotic vector
Hitoshi, N., Ken-ichi, Y., & Jun-ichi, M. (1991) · Gene · doi:10.1016/0378-1119(91)90434-d · Cited by 5,134
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
Self-citationIn vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., & Yamanaka, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1374 · Cited by 2,380
Self-citationMaherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Plat-E: an efficient and stable system for transient packaging of retroviruses
Morita, S., Kojima, T., & Kitamura, T. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301206 · Cited by 1,660
Cited by
Items 101–136 of 136
The promises and perils of p53
Krizhanovsky, V., & Lowe, S. W. (2009) · Nature · doi:10.1038/4601085a · Cited by 274
Sommer, C. A., Sommer, A. G., Longmire, T. A., Christodoulou, C., Thomas, D. D., Gostissa, M., Alt, F. W., Murphy, G. J., Kotton, D. N., & Mostoslavsky, G. (2010) · Stem Cells · doi:10.1002/stem.255 · Cited by 269
Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications
Yoshida, Y., & Yamanaka, S. (2017) · Circulation Research · doi:10.1161/circresaha.117.311080 · Cited by 264
Self-citationA Comparative View on Human Somatic Cell Sources for iPSC Generation
Raab, S., Klingenstein, M., Liebau, S., & Linta, L. (2014) · Stem Cells International · doi:10.1155/2014/768391 · Cited by 263
“Moreover, also these systems exhibit a low reprogramming efficiency compared to other systems [10, 21].”
BackgroundMethodTissue Engineering and Regenerative Medicine: Recent Innovations and the Transition to Translation
Fisher, M. B., & Mauck, R. L. (2013) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2012.0723 · Cited by 263
Rufaihah, A. J., Huang, N. F., Jamé, S., Lee, J. C., Nguyen, H. N., Byers, B., De, A., Okogbaa, J., Rollins, M., Reijo-Pera, R., et al. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.230938 · Cited by 263
Induced pluripotent stem cells: opportunities and challenges
Okita, K., & Yamanaka, S. (2011) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0016 · Cited by 261
Self-citationPhenotypic correction of murine hemophilia A using an iPS cell-based therapy
Xu, D., Alipio, Z., Fink, L. M., Adcock, D. M., Yang, J., Ward, D. C., & Ma, Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812090106 · Cited by 261
Complete Genetic Correction of iPS Cells From Duchenne Muscular Dystrophy
Kazuki, Y., Hiratsuka, M., Takiguchi, M., Osaki, M., Kajitani, N., Hoshiya, H., Hiramatsu, K., Yoshino, T., Kazuki, K., Ishihara, C., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2009.274 · Cited by 259
Self-citationWarlich, E., Kuehle, J., Cantz, T., Brugman, M. H., Maetzig, T., Galla, M., Filipczyk, A. A., Halle, S., Klump, H., Schöler, H. R., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2010.314 · Cited by 259
Margariti, A., Winkler, B., Karamariti, E., Zampetaki, A., Tsai, T.-N., Baban, D., Ragoussis, J., Huang, Y., Han, J.-D. J., Zeng, L., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205526109 · Cited by 258
Mica, Y., Lee, G., Chambers, S. M., Tomishima, M. J., & Studer, L. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.03.025 · Cited by 257
Hu, K., Yu, J., Suknuntha, K., Tian, S., Montgomery, K., Choi, K.-D., Stewart, R., Thomson, J. A., & Slukvin, I. I. (2011) · Blood · doi:10.1182/blood-2010-07-298331 · Cited by 254
Efficient Feeder-Free Episomal Reprogramming with Small Molecules
Yu, J., Chau, K. F., Vodyanik, M. A., Jiang, J., & Jiang, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017557 · Cited by 254
Cho, H.-J., Lee, C.-S., Kwon, Y.-W., Paek, J. S., Lee, S.-H., Hur, J., Lee, E. J., Roh, T.-Y., Chu, I.-S., Leem, S.-H., et al. (2010) · Blood · doi:10.1182/blood-2010-02-269589 · Cited by 239
Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors
Narsinh, K. H., Jia, F., Robbins, R. C., Kay, M. A., Longaker, M. T., & Wu, J. C. (2011) · Nature Protocols · doi:10.1038/nprot.2010.173 · Cited by 214
Theodoris, C. V., Li, M., White, M. P., Liu, L., He, D., Pollard, K. S., Bruneau, B. G., & Srivastava, D. (2015) · Cell · doi:10.1016/j.cell.2015.02.035 · Cited by 210
Complex architecture and regulated expression of the Sox2ot locus during vertebrate development
Amaral, P. P., Neyt, C., Wilkins, S. J., Askarian-Amiri, M. E., Sunkin, S. M., Perkins, A. C., & Mattick, J. S. (2009) · RNA · doi:10.1261/rna.1705309 · Cited by 209
Liu, X., Sun, H., Qi, J., Wang, L., He, S., Liu, J., Feng, C., Chen, C., Li, W., Guo, Y., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2765 · Cited by 208
Stem Cell Therapy for Vascular Regeneration: Adult, Embryonic, and Induced Pluripotent Stem Cells
Leeper, N. J., Hunter, A. L., & Cooke, J. P. (2010) · Circulation · doi:10.1161/circulationaha.109.881441 · Cited by 195
Feeder-Free Derivation of Human Induced Pluripotent Stem Cells with Messenger RNA
Warren, L., Ni, Y., Wang, J., & Guo, X. (2012) · Scientific Reports · doi:10.1038/srep00657 · Cited by 154
Induced Pluripotent Stem Cells from Individuals with Recessive Dystrophic Epidermolysis Bullosa
Tolar, J., Xia, L., Riddle, M. J., Lees, C. J., Eide, C. R., McElmurry, R. T., Titeux, M., Osborn, M. J., Lund, T. C., Hovnanian, A., et al. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.346 · Cited by 155
Nanomedicine-Based Approaches for mRNA Delivery
Uchida, S., Perche, F., Pichon, C., & Cabral, H. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00618 · Cited by 139
Overcoming the Specific Toxicity of Large Plasmids Electrotransfer in Primary Cells In Vitro
Lesueur, L. L., Mir, L. M., & André, F. M. (2016) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2016.4 · Cited by 118
Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity
Wu, C., & Dunbar, C. E. (2011) · Frontiers of Medicine · doi:10.1007/s11684-011-0159-1 · Cited by 114
iPSC Preparation and Epigenetic Memory: Does the Tissue Origin Matter?
Scesa, G., Adami, R., & Bottai, D. (2021) · Cells · doi:10.3390/cells10061470 · Cited by 110
Bioengineering a 3D integumentary organ system from iPS cells using an in vivo transplantation model
Takagi, R., Ishimaru, J., Sugawara, A., Toyoshima, K.-E., Ishida, K., Ogawa, M., Sakakibara, K., Asakawa, K., Kashiwakura, A., Oshima, M., et al. (2016) · Science Advances · doi:10.1126/sciadv.1500887 · Cited by 107
All Roads Lead to Induced Pluripotent Stem Cells: The Technologies of iPSC Generation
Hu, K. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0620 · Cited by 105
Stem cell sources for vascular tissue engineering and regeneration
Bajpai, V. K., & Andreadis, S. T. (2012) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2011.0264 · Cited by 95
Vascularized subcutaneous human liver tissue from engineered hepatocyte/fibroblast sheets in mice
Sakai, Y., Yamanouchi, K., Ohashi, K., Koike, M., Utoh, R., Hasegawa, H., Muraoka, I., Suematsu, T., Soyama, A., Hidaka, M., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.06.046 · Cited by 65
Genomic imprinting as an adaptative model of developmental plasticity
Radford, E. J., Ferrón, S. R., & Ferguson-Smith, A. C. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.05.063 · Cited by 64
Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes
Giacomelli, E., Mummery, C. L., & Bellin, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2546-5 · Cited by 60
Design, Assembly, Production, and Transfection of Synthetic Modified mRNA
Oh, S., & Kessler, J. A. (2018) · Methods · doi:10.1016/j.ymeth.2017.10.008 · Cited by 58
Applications of induced pluripotent stem cells in studying the neurodegenerative diseases
Wan, W., Cao, L., Kalionis, B., Xia, S., & Tai, X. (2015) · Stem Cells International · doi:10.1155/2015/382530 · Cited by 40
Tomaru, Y., Hasegawa, R., Suzuki, T., Sato, T., Kubosaki, A., Suzuki, M., Kawaji, H., Forrest, A. R. R., Hayashizaki, Y., FANTOM Consortium, et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku567 · Cited by 39
Human iPSC Models in Drug Discovery: Opportunities and Challenges
Silva, M. C., Cross, A., Brandon, N. J., & Haggarty, S. J. (2017) · Comprehensive Medicinal Chemistry III · doi:10.1016/b978-0-12-409547-2.12284-x · Cited by 6
Metadata
- Authors
- Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T., & Yamanaka, S.
- Venue
- Science
- Published
- 2008-11-07
- Volume
- 322
- Issue
- 5903
- Pages
- 949-953
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2032570745
- Cited by
- 2,009
- References
- 20
- FWCI
- 93.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.